Macropa-NH2, a H2macropa derivative with an macrocyclic core of macropa, can be used in targeted cancer therapy research[1].
[1]. Thiele NA, et al. An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy. Angew Chem Int Ed Engl. 2017 Nov 13;56(46):14712-14717.
















